Annual report
7730.TEDINET S100SC8R
Period2022-09-01 → 2023-08-31
Filed2023-11-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥24.5bn | 2022-09-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥20.4bn | 2021-09-01 → 2022-08-31 | Cons. | Net sales |
| Revenue | ¥17.2bn | 2020-09-01 → 2021-08-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.2bn | 2019-09-01 → 2020-08-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.3bn | 2018-09-01 → 2019-08-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥7.2bn | 2022-09-01 → 2023-08-31 | Cons. | Operating income |
| Operating income | ¥6.2bn | 2021-09-01 → 2022-08-31 | Cons. | Operating income |
| Ordinary income | ¥8.0bn | 2022-09-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥7.5bn | 2021-09-01 → 2022-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.7bn | 2020-09-01 → 2021-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.4bn | 2019-09-01 → 2020-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.7bn | 2018-09-01 → 2019-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥8.0bn | 2022-09-01 → 2023-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥7.4bn | 2021-09-01 → 2022-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥6.0bn | 2022-09-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.3bn | 2021-09-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.3bn | 2020-09-01 → 2021-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.3bn | 2019-09-01 → 2020-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.1bn | 2018-09-01 → 2019-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥6.0bn | 2022-09-01 → 2023-08-31 | Cons. | Profit loss |
| Net income | ¥5.3bn | 2021-09-01 → 2022-08-31 | Cons. | Profit loss |
| Total assets | ¥55.0bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥50.1bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥42.7bn | at 2021-08-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥39.3bn | at 2020-08-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥39.8bn | at 2019-08-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.1bn | at 2023-08-31 | Cons. | Liabilities |
| Total liabilities | ¥4.7bn | at 2022-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥49.8bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥45.4bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥39.2bn | at 2021-08-31d | Cons. | Net assets |
| Net assets / equity | ¥36.6bn | at 2020-08-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥35.3bn | at 2019-08-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥25.4bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥22.7bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥23.8bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.1bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.1bn | at 2021-08-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥17.0bn | at 2020-08-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥16.1bn | at 2019-08-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥8.0bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.6bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.4bn | 2020-09-01 → 2021-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.9bn | 2019-09-01 → 2020-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.3bn | 2018-09-01 → 2019-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥4.0bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.4bn | 2020-09-01 → 2021-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥38m | 2019-09-01 → 2020-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥810m | 2018-09-01 → 2019-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥3.3bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.4bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.2bn | 2020-09-01 → 2021-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.1bn | 2019-09-01 → 2020-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.8bn | 2018-09-01 → 2019-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥60.46 | 2022-09-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.75 | 2021-09-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.6 | 2020-09-01 → 2021-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.83 | 2019-09-01 → 2020-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.99 | 2018-09-01 → 2019-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥505.88 | at 2023-08-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥461.41 | at 2022-08-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥398.29 | at 2021-08-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥371.51 | at 2020-08-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥358.92 | at 2019-08-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 90.6% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.6% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.8% | at 2021-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.1% | at 2020-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.7% | at 2019-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.5% | 2022-09-01 → 2023-08-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.5% | 2021-09-01 → 2022-08-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2020-09-01 → 2021-08-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2019-09-01 → 2020-08-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.7% | 2018-09-01 → 2019-08-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,685 | at 2023-08-31 | Cons. | Number of employees |
| Employees | 3,417 | at 2022-08-31 | Cons. | Number of employees |
| Employees | 3,313 | at 2021-08-31d | Cons. | Number of employees |
| Employees | 3,812 | at 2020-08-31d | Cons. | Number of employees |
| Employees | 3,810 | at 2019-08-31d | Cons. | Number of employees |
| Revenue | ¥21.3bn | 2022-09-01 → 2023-08-31 | Standalone | Net sales |
| Revenue | ¥17.6bn | 2021-09-01 → 2022-08-31 | Standalone | Net sales |
| Revenue | ¥14.8bn | 2020-09-01 → 2021-08-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥13.8bn | 2019-09-01 → 2020-08-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.6bn | 2018-09-01 → 2019-08-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥5.4bn | 2022-09-01 → 2023-08-31 | Standalone | Operating income |
| Operating income | ¥4.2bn | 2021-09-01 → 2022-08-31 | Standalone | Operating income |
| Ordinary income | ¥6.2bn | 2022-09-01 → 2023-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥7.5bn | 2021-09-01 → 2022-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.7bn | 2020-09-01 → 2021-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.2bn | 2019-09-01 → 2020-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.5bn | 2018-09-01 → 2019-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥6.3bn | 2022-09-01 → 2023-08-31 | Standalone | Income before income taxes |
| Profit before tax | ¥7.4bn | 2021-09-01 → 2022-08-31 | Standalone | Income before income taxes |
| Net income | ¥4.5bn | 2022-09-01 → 2023-08-31 | Standalone | Profit loss |
| Net income | ¥5.5bn | 2021-09-01 → 2022-08-31 | Standalone | Profit loss |
| Net income | ¥3.4bn | 2020-09-01 → 2021-08-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.4bn | 2019-09-01 → 2020-08-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥5.2bn | 2018-09-01 → 2019-08-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥43.5bn | at 2023-08-31 | Standalone | Assets |
| Total assets | ¥41.3bn | at 2022-08-31 | Standalone | Assets |
| Total assets | ¥37.2bn | at 2021-08-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥35.3bn | at 2020-08-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥36.1bn | at 2019-08-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥4.5bn | at 2023-08-31 | Standalone | Liabilities |
| Total liabilities | ¥3.8bn | at 2022-08-31 | Standalone | Liabilities |
| Net assets / equity | ¥39.0bn | at 2023-08-31 | Standalone | Net assets |
| Net assets / equity | ¥37.5bn | at 2022-08-31 | Standalone | Net assets |
| Net assets / equity | ¥34.4bn | at 2021-08-31d | Standalone | Net assets |
| Net assets / equity | ¥33.2bn | at 2020-08-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥32.2bn | at 2019-08-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥17.5bn | at 2023-08-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥15.2bn | at 2022-08-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥45.69 | 2022-09-01 → 2023-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.9 | 2021-09-01 → 2022-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.98 | 2020-09-01 → 2021-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.31 | 2019-09-01 → 2020-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.59 | 2018-09-01 → 2019-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥35 | 2022-09-01 → 2023-08-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2021-09-01 → 2022-08-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥23 | 2020-09-01 → 2021-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥22 | 2019-09-01 → 2020-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2018-09-01 → 2019-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥396.29 | at 2023-08-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥381.33 | at 2022-08-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥349.63 | at 2021-08-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥337.38 | at 2020-08-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥327.15 | at 2019-08-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 89.7% | at 2023-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.9% | at 2022-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.4% | at 2021-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.1% | at 2020-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.2% | at 2019-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.8% | 2022-09-01 → 2023-08-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.3% | 2021-09-01 → 2022-08-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2020-09-01 → 2021-08-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2019-09-01 → 2020-08-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.4% | 2018-09-01 → 2019-08-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 106,981,502 | at 2023-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,911,000 | at 2022-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,911,000 | at 2021-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,911,000 | at 2020-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,637,000 | at 2019-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 366 | at 2023-08-31 | Standalone | Number of employees |
| Employees | 350 | at 2022-08-31 | Standalone | Number of employees |
| Employees | 333 | at 2021-08-31d | Standalone | Number of employees |
| Employees | 320 | at 2020-08-31d | Standalone | Number of employees |
| Employees | 315 | at 2019-08-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-09-01 → 2023-08-31 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-09-01 → 2023-08-31 | −¥1m |
| Dental Related Productsreportable segment | depreciation | 2022-09-01 → 2023-08-31 | ¥818m |
| Dental Related Productsreportable segment | employees | at 2023-08-31 | 1094 pure |
| Dental Related Productsreportable segment | revenue | 2022-09-01 → 2023-08-31 | ¥9.1bn |
| Dental Related Productsreportable segment | revenue external | 2022-09-01 → 2023-08-31 | ¥9.1bn |
| Dental Related Productsreportable segment | segment profit | 2022-09-01 → 2023-08-31 | ¥2.3bn |
| Eyeless Needle Related Productsreportable segment | depreciation | 2022-09-01 → 2023-08-31 | ¥709m |
| Eyeless Needle Related Productsreportable segment | employees | at 2023-08-31 | 1514 pure |
| Eyeless Needle Related Productsreportable segment | revenue | 2022-09-01 → 2023-08-31 | ¥8.6bn |
| Eyeless Needle Related Productsreportable segment | revenue external | 2022-09-01 → 2023-08-31 | ¥8.6bn |
| Eyeless Needle Related Productsreportable segment | revenue intersegment | 2022-09-01 → 2023-08-31 | ¥1m |
| Eyeless Needle Related Productsreportable segment | segment profit | 2022-09-01 → 2023-08-31 | ¥2.9bn |
| Surgel Related Productsreportable segment | depreciation | 2022-09-01 → 2023-08-31 | ¥389m |
| Surgel Related Productsreportable segment | employees | at 2023-08-31 | 644 pure |
| Surgel Related Productsreportable segment | revenue | 2022-09-01 → 2023-08-31 | ¥6.8bn |
| Surgel Related Productsreportable segment | revenue external | 2022-09-01 → 2023-08-31 | ¥6.8bn |
| Surgel Related Productsreportable segment | segment profit | 2022-09-01 → 2023-08-31 | ¥2.1bn |
| —segment total | depreciation | 2022-09-01 → 2023-08-31 | ¥1.9bn |
| —segment total | revenue | 2022-09-01 → 2023-08-31 | ¥24.5bn |
| —segment total | revenue external | 2022-09-01 → 2023-08-31 | ¥24.5bn |
| —segment total | revenue intersegment | 2022-09-01 → 2023-08-31 | ¥1m |
| —segment total | segment profit | 2022-09-01 → 2023-08-31 | ¥7.2bn |
| Reconciling Itemsreconciling | revenue | 2021-09-01 → 2022-08-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-09-01 → 2022-08-31 | −¥2m |
| Dental Related Productsreportable segment | depreciation | 2021-09-01 → 2022-08-31 | ¥695m |
| Dental Related Productsreportable segment | revenue | 2021-09-01 → 2022-08-31 | ¥8.2bn |
| Dental Related Productsreportable segment | revenue external | 2021-09-01 → 2022-08-31 | ¥8.2bn |
| Dental Related Productsreportable segment | segment profit | 2021-09-01 → 2022-08-31 | ¥2.4bn |
| Eyeless Needle Related Productsreportable segment | depreciation | 2021-09-01 → 2022-08-31 | ¥617m |
| Eyeless Needle Related Productsreportable segment | revenue | 2021-09-01 → 2022-08-31 | ¥6.3bn |
| Eyeless Needle Related Productsreportable segment | revenue external | 2021-09-01 → 2022-08-31 | ¥6.3bn |
| Eyeless Needle Related Productsreportable segment | revenue intersegment | 2021-09-01 → 2022-08-31 | ¥2m |
| Eyeless Needle Related Productsreportable segment | segment profit | 2021-09-01 → 2022-08-31 | ¥1.8bn |
| Surgel Related Productsreportable segment | depreciation | 2021-09-01 → 2022-08-31 | ¥356m |
| Surgel Related Productsreportable segment | revenue | 2021-09-01 → 2022-08-31 | ¥6.0bn |
| Surgel Related Productsreportable segment | revenue external | 2021-09-01 → 2022-08-31 | ¥6.0bn |
| Surgel Related Productsreportable segment | segment profit | 2021-09-01 → 2022-08-31 | ¥2.0bn |
| —segment total | depreciation | 2021-09-01 → 2022-08-31 | ¥1.7bn |
| —segment total | revenue | 2021-09-01 → 2022-08-31 | ¥20.4bn |
| —segment total | revenue external | 2021-09-01 → 2022-08-31 | ¥20.4bn |
| —segment total | revenue intersegment | 2021-09-01 → 2022-08-31 | ¥2m |
| —segment total | segment profit | 2021-09-01 → 2022-08-31 | ¥6.2bn |
| Dental Related Productsreportable segment | employees | at 2023-08-31 | 103 pure |
| Eyeless Needle Related Productsreportable segment | employees | at 2023-08-31 | 55 pure |
| Surgel Related Productsreportable segment | employees | at 2023-08-31 | 96 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,503
| Item | Context | Value | Unit |
|---|---|---|---|
| Accounts payable trade | CurrentYearInstant | 159000000 | JPY |
| Accounts payable other | Prior1YearInstant | 934000000 | JPY |
| Accounts payable other | CurrentYearInstant | 1047000000 | JPY |
| Lease obligations cl | Prior1YearInstant | 87000000 | JPY |
| Lease obligations cl | CurrentYearInstant | 41000000 | JPY |
| Income taxes payable | Prior1YearInstant | 1148000000 | JPY |
| Income taxes payable | CurrentYearInstant | 1186000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 639000000 | JPY |
| Provision for bonuses | CurrentYearInstant | 798000000 | JPY |
| Other cl | Prior1YearInstant | 861000000 | JPY |
| Other cl | CurrentYearInstant | 986000000 | JPY |
| Current liabilities | Prior1YearInstant | 3784000000 | JPY |
| Current liabilities | CurrentYearInstant | 4218000000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 30000000 | JPY |
| Lease obligations ncl | CurrentYearInstant | 17000000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 59000000 | JPY |
| Provision for directors retirement benefits | CurrentYearInstant | － | JPY |
| Net defined benefit liability | Prior1YearInstant | 589000000 | JPY |
| Net defined benefit liability | CurrentYearInstant | 598000000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 201000000 | JPY |
| Asset retirement obligations ncl | CurrentYearInstant | 223000000 | JPY |
| Other ncl | Prior1YearInstant | 34000000 | JPY |
| Other ncl | CurrentYearInstant | 91000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 914000000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 931000000 | JPY |
| Liabilities | Prior1YearInstant | 4698000000 | JPY |
| Liabilities | CurrentYearInstant | 5149000000 | JPY |
| Capital stock | Prior1YearInstant | 988000000 | JPY |
| Capital stock | CurrentYearInstant | 1066000000 | JPY |
| Capital surplus | Prior1YearInstant | 1036000000 | JPY |
| Capital surplus | CurrentYearInstant | 1113000000 | JPY |
| Retained earnings | Prior1YearInstant | 42678000000 | JPY |
| Retained earnings | CurrentYearInstant | 45482000000 | JPY |
| Treasury stock | Prior1YearInstant | -3125000000 | JPY |
| Treasury stock | CurrentYearInstant | -3125000000 | JPY |
| Shareholders equity | Prior1YearInstant | 41578000000 | JPY |
| Shareholders equity | CurrentYearInstant | 44536000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 21000000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 17000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 3845000000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | 5251000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -30000000 | JPY |
| Remeasurements of defined benefit plans | CurrentYearInstant | 21000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 3836000000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 5290000000 | JPY |
| Net assets | Prior1YearInstant | 45414000000 | JPY |
| Net assets | CurrentYearInstant | 49827000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 50113000000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 54977000000 | JPY |
| Net sales | Prior1YearDuration | 20416000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |